恩瑞格主治什么病症？

(Deferasirox) is a life-saving drug for patients with thalassemia. Although blood transfusion and iron removal may alleviate the progression of the disease, the effect is not as obvious as Enrig. Moreover, Enrig is more convenient to take and does not cause too much discomfort to the patient.

So, what diseases does Enrig treat?

Indications for Deferasirox:

1. Enrig can be used to treat reversible renal insufficiency caused by Fanconi syndrome.

2. For the treatment of secondary hemochromatosis.

3. Can be used to treat porphyria cutaneous tarda.

4. For the treatment of myelodysplastic syndrome.

5. Used to treat iron overload caused by blood transfusion in patients with chronic anemia 2 years old and above.

Patients should pay attention to the following when using Deferasirox dispersible tablets:

1. Enriga may cause a rash. Generally, the rash will disappear automatically without the need to adjust the dose or stop the medication. If the condition is serious or persistent, the medication should be stopped.

2. The patient’s vision or hearing may be affected.

3. It should be taken 30 minutes before meals.

4. It should be taken at the same time every day.

5. Enrig dispersible tablets should not be taken together with aluminum-containing antacids. The dosage (mg/kg) needs to be calculated and rounded to the nearest whole tablet.

6. The medicine must be mixed with a small amount of water, apple juice or orange juice before taking it. Dissolving in carbonated drinks and milk is not recommended as it can cause foaming and slow dispersion.

7. If you are using other drugs, please consult your physician or pharmacist before using this product.

8. Drug interactions may occur if used together with other drugs. Please consult your physician or pharmacist for details.

Before taking (Deferasirox), patients need to carefully read the precautions for Enrego Dispersible Tablets. They are responsible for their own health. We hope it will be helpful to patients who use this medicine.